Deerfield Management’s GSK GSK Stock Holding History

Deerfield Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-648,000	Closed	-$31.6M	–	117
2018 Q1	$31.6M	Buy	+648,000	New	+$30.2M	1.1%	30
2016 Q2	–	Sell	-1,340,308	Closed	-$67.9M	–	109
2016 Q1	$67.9M	Hold	1,340,308	–	–	2.89%	6
2015 Q4	$67.6M	Sell	1,340,308 -485,870	-27%	-$24.8M	2.74%	5
2015 Q3	$87.8M	Buy	1,826,178 +724,800	+66%	+$37.7M	3.4%	4
2015 Q2	$57.3M	Buy	1,101,378 +402,830	+58%	+$22.7M	1.91%	9
2015 Q1	$40.3M	Buy	698,548 +247,908	+55%	+$14.2M	1.31%	20
2014 Q4	$24.1M	Buy	450,640 +130,640	+41%	+$7.31M	0.86%	33
2014 Q3	$18.4M	Buy	+320,000	New	+$19.6M	0.67%	50

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deerfield Management's GSK Position: Q2 2018 in Review

Deerfield Management sold out of GSK (GSK) in Q2 2018, closing a stake of 648,000 shares — an estimated $31.6M sold.

Deerfield Management first reported a position in GSK in Q3 2014 and held it in 8 quarters. The position peaked at $87.8M in Q3 2015. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

Deerfield Management reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
Deerfield Management sold 648,000 GSK shares in Q2 2018, an estimated $31.6M.
Deerfield Management first reported a position in GSK in Q3 2014 and held it in 8 quarters.
Deerfield Management's GSK position peaked at $87.8M in Q3 2015.
787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Deerfield Management's 13F filing for Q2 2018, filed 14 Aug 2018.